Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ARTICLE
Year: 2019   |   Volume: 8   |   Issue: 6   |   Page: 254-256     View issue

Primary neuroendocrine tumor of breast: Diagnosing and treating a rare case


Poorva Vias, Kislay Dimri, Awadhesh Pandey, Nidhi Prinja, Ranjeev Bhagat
Abstract

Neuroendocrine carcinoma breast is a distinct entity. Although clinical features and morphology cannot distinguish it from invasive carcinomas, immunochemistry plays an important role in it. Due to its rarity and lack of clinical data, treatment is followed on the lines of invasive breast carcinoma. Some studies have suggested the use of cisplatin and etoposide for its treatment, but none of them is standard. The prognosis is poor compared to invasive breast cancer.

Cite this article
Vancouver
Vias P, Dimri K, Pandey A, Prinja N, Bhagat R. Primary neuroendocrine tumor of breast: Diagnosing and treating a rare case. Clin Cancer Investig J. 2019;8(6):254-6. https://doi.org/10.4103/ccij.ccij_79_19
APA
Vias, P., Dimri, K., Pandey, A., Prinja, N., & Bhagat, R. (2019). Primary neuroendocrine tumor of breast: Diagnosing and treating a rare case. Clinical Cancer Investigation Journal, 8(6), 254-256. https://doi.org/10.4103/ccij.ccij_79_19

Sitemap | What's New | Feedback | Copyright and Disclaimer | Privacy Notice
© Clinical Cancer Investigation Journal | Published by Polaris Publication
Online since 01 December, 2011
Editorial and Ethics Policies
Creative Commons  Open Access Journal View mobile site 
ISSN: Print -2278-1668, Online - 2278-0513